Citadel Advisors’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.29M | Buy |
+521,508
| New | +$1.29M | ﹤0.01% | 3065 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 6718 |
|
|
2024
Q4 | – | Sell |
-50,995
| Closed | -$197K | – | 6588 |
|
|
2024
Q3 | $197K | Buy |
50,995
+38,269
| +301% | +$148K | ﹤0.01% | 4637 |
|
|
2024
Q2 | $65.4K | Sell |
12,726
-95,472
| -88% | -$491K | ﹤0.01% | 5098 |
|
|
2024
Q1 | $757K | Buy |
+108,198
| New | +$757K | ﹤0.01% | 3476 |
|
|
2023
Q4 | – | Sell |
-6,524
| Closed | -$62.2K | – | 6490 |
|
|
2023
Q3 | $62.2K | Buy |
+6,524
| New | +$62.2K | ﹤0.01% | 5001 |
|